MicroRNA-200 family members and ZEB2 are associated with brain metastasis in gastric adenocarcinoma

Yang Ki Minn, Da Hye Lee, WooJin Hyung, Ji Eun Kim, Junjeong Choi, Seung Ho Yang, Hotaek Song, Beom Jin Lim, SeHoon Kim

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Although the incidence of brain metastasis in gastric cancer is relatively low, its prevalence may increase with improved therapy and longer survival tumors. The molecular mechanisms underlying brain metastases are not well understood. To gain insight into the mechanism of brain metastasis, we studied differences in microRNA (miRNA) expression levels in 8 cases of matched primary gastric adenocarcinoma and brain metastatic adenocarcinoma using the Illumina microRNA microarray chip. We identified 6 upregulated and 2 downregulated miRNAs in all 8 cases simultaneously. Interestingly, 2 out of 8 miRNAs (hsa-miR-141-3p and hsa-miR-200b-3p) belonged to the miR-200 family. Online microRNA database searching revealed that ZEB2 is the topranked target gene for hsa-miR141-3p and hsa-miR-200b-3p, prompting us to focus ZEB2 expression in brain metastatic adenocarcinoma. We confirmed that ZEB2 expression was markedly downregulated in some brain metastatic samples. In addition, decreased ZEB2 expression was noted by western blot analysis of 2 metastatic gastric adenocarcinoma cell types that were derived by in vivo selection following intracardiac injection of gastric cancer cell lines. In conclusion, we demonstrate that expression of miRNA-200 family members and ZEB2 are associated with brain metastases of gastric adenocarcinoma, not only in matched patient samples, but also in metastatic cell lines that were derived by in vivo selection.

Original languageEnglish
Pages (from-to)2403-2410
Number of pages8
JournalInternational Journal of Oncology
Volume45
Issue number6
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

MicroRNAs
Stomach
Adenocarcinoma
Neoplasm Metastasis
Brain
Stomach Neoplasms
Down-Regulation
Cell Line
Western Blotting
Databases
Injections
Survival
Incidence
Genes
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Minn, Yang Ki ; Lee, Da Hye ; Hyung, WooJin ; Kim, Ji Eun ; Choi, Junjeong ; Yang, Seung Ho ; Song, Hotaek ; Lim, Beom Jin ; Kim, SeHoon. / MicroRNA-200 family members and ZEB2 are associated with brain metastasis in gastric adenocarcinoma. In: International Journal of Oncology. 2014 ; Vol. 45, No. 6. pp. 2403-2410.
@article{b2fd4e6f43d143fcb09a856ed4005bf0,
title = "MicroRNA-200 family members and ZEB2 are associated with brain metastasis in gastric adenocarcinoma",
abstract = "Although the incidence of brain metastasis in gastric cancer is relatively low, its prevalence may increase with improved therapy and longer survival tumors. The molecular mechanisms underlying brain metastases are not well understood. To gain insight into the mechanism of brain metastasis, we studied differences in microRNA (miRNA) expression levels in 8 cases of matched primary gastric adenocarcinoma and brain metastatic adenocarcinoma using the Illumina microRNA microarray chip. We identified 6 upregulated and 2 downregulated miRNAs in all 8 cases simultaneously. Interestingly, 2 out of 8 miRNAs (hsa-miR-141-3p and hsa-miR-200b-3p) belonged to the miR-200 family. Online microRNA database searching revealed that ZEB2 is the topranked target gene for hsa-miR141-3p and hsa-miR-200b-3p, prompting us to focus ZEB2 expression in brain metastatic adenocarcinoma. We confirmed that ZEB2 expression was markedly downregulated in some brain metastatic samples. In addition, decreased ZEB2 expression was noted by western blot analysis of 2 metastatic gastric adenocarcinoma cell types that were derived by in vivo selection following intracardiac injection of gastric cancer cell lines. In conclusion, we demonstrate that expression of miRNA-200 family members and ZEB2 are associated with brain metastases of gastric adenocarcinoma, not only in matched patient samples, but also in metastatic cell lines that were derived by in vivo selection.",
author = "Minn, {Yang Ki} and Lee, {Da Hye} and WooJin Hyung and Kim, {Ji Eun} and Junjeong Choi and Yang, {Seung Ho} and Hotaek Song and Lim, {Beom Jin} and SeHoon Kim",
year = "2014",
month = "1",
day = "1",
doi = "10.3892/ijo.2014.2680",
language = "English",
volume = "45",
pages = "2403--2410",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "6",

}

MicroRNA-200 family members and ZEB2 are associated with brain metastasis in gastric adenocarcinoma. / Minn, Yang Ki; Lee, Da Hye; Hyung, WooJin; Kim, Ji Eun; Choi, Junjeong; Yang, Seung Ho; Song, Hotaek; Lim, Beom Jin; Kim, SeHoon.

In: International Journal of Oncology, Vol. 45, No. 6, 01.01.2014, p. 2403-2410.

Research output: Contribution to journalArticle

TY - JOUR

T1 - MicroRNA-200 family members and ZEB2 are associated with brain metastasis in gastric adenocarcinoma

AU - Minn, Yang Ki

AU - Lee, Da Hye

AU - Hyung, WooJin

AU - Kim, Ji Eun

AU - Choi, Junjeong

AU - Yang, Seung Ho

AU - Song, Hotaek

AU - Lim, Beom Jin

AU - Kim, SeHoon

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Although the incidence of brain metastasis in gastric cancer is relatively low, its prevalence may increase with improved therapy and longer survival tumors. The molecular mechanisms underlying brain metastases are not well understood. To gain insight into the mechanism of brain metastasis, we studied differences in microRNA (miRNA) expression levels in 8 cases of matched primary gastric adenocarcinoma and brain metastatic adenocarcinoma using the Illumina microRNA microarray chip. We identified 6 upregulated and 2 downregulated miRNAs in all 8 cases simultaneously. Interestingly, 2 out of 8 miRNAs (hsa-miR-141-3p and hsa-miR-200b-3p) belonged to the miR-200 family. Online microRNA database searching revealed that ZEB2 is the topranked target gene for hsa-miR141-3p and hsa-miR-200b-3p, prompting us to focus ZEB2 expression in brain metastatic adenocarcinoma. We confirmed that ZEB2 expression was markedly downregulated in some brain metastatic samples. In addition, decreased ZEB2 expression was noted by western blot analysis of 2 metastatic gastric adenocarcinoma cell types that were derived by in vivo selection following intracardiac injection of gastric cancer cell lines. In conclusion, we demonstrate that expression of miRNA-200 family members and ZEB2 are associated with brain metastases of gastric adenocarcinoma, not only in matched patient samples, but also in metastatic cell lines that were derived by in vivo selection.

AB - Although the incidence of brain metastasis in gastric cancer is relatively low, its prevalence may increase with improved therapy and longer survival tumors. The molecular mechanisms underlying brain metastases are not well understood. To gain insight into the mechanism of brain metastasis, we studied differences in microRNA (miRNA) expression levels in 8 cases of matched primary gastric adenocarcinoma and brain metastatic adenocarcinoma using the Illumina microRNA microarray chip. We identified 6 upregulated and 2 downregulated miRNAs in all 8 cases simultaneously. Interestingly, 2 out of 8 miRNAs (hsa-miR-141-3p and hsa-miR-200b-3p) belonged to the miR-200 family. Online microRNA database searching revealed that ZEB2 is the topranked target gene for hsa-miR141-3p and hsa-miR-200b-3p, prompting us to focus ZEB2 expression in brain metastatic adenocarcinoma. We confirmed that ZEB2 expression was markedly downregulated in some brain metastatic samples. In addition, decreased ZEB2 expression was noted by western blot analysis of 2 metastatic gastric adenocarcinoma cell types that were derived by in vivo selection following intracardiac injection of gastric cancer cell lines. In conclusion, we demonstrate that expression of miRNA-200 family members and ZEB2 are associated with brain metastases of gastric adenocarcinoma, not only in matched patient samples, but also in metastatic cell lines that were derived by in vivo selection.

UR - http://www.scopus.com/inward/record.url?scp=84907702614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907702614&partnerID=8YFLogxK

U2 - 10.3892/ijo.2014.2680

DO - 10.3892/ijo.2014.2680

M3 - Article

VL - 45

SP - 2403

EP - 2410

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 6

ER -